Patents by Inventor Salvador GENOVÉS MARTÍNEZ

Salvador GENOVÉS MARTÍNEZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF PROBIOTICS IN THE TREATMENT AND/OR PREVENTION OF ATOPIC DERMATITIS
    Publication number: 20230048705
    Abstract: The present invention is intended for the use of a probiotic composition comprising Bifidobacterium animalis subs. lactis (B. lactis), Bifidobacterium longum and Lactobacillus casei, particularly the strains B. lactis CECT 8145, B. longum CECT 7347 and/or L. casei CECT 9104, in the treatment and/or prevention of atopic dermatitis.
    Type: Application
    Filed: August 15, 2022
    Publication date: February 16, 2023
    Inventors: Vicente Manuel NAVARRO LÓPEZ, Ana Adela RAMÍREZ BOSCÁ, José Manuel PÉREZ ORQUÍN, Daniel RAMÓN VIDAL, Salvador GENOVÉS MARTÍNEZ, María Empar CHENOLL CUADROS, Francisco Manuel CODOÑER CORTÉS
  • PROBIOTIC COMPOSITION FOR USE AS AN ANTIOXIDANT
    Publication number: 20230028548
    Abstract: This invention refers to a probiotic composition consisting of the bacteria Lactobacillus rhamnosus, Lactobacillus casei and Bifidobacterium longum, preferably of the strains L. rhamnosus CECT8361, L. casei CECT9104 and B. longum CECT7347, and its use as an antioxidant. This composition is particularly useful in the treatment and/or prevention of damage, at the molecular level, caused by oxidative stress, preferably during high intensity physical exercise.
    Type: Application
    Filed: January 14, 2021
    Publication date: January 26, 2023
    Inventors: Maria Empar CHENOLL CUADROS, Patricia MARTORELL GUEROLA, Salvador GENOVÉS MARTÍNEZ, Daniel RAMÓN VIDAL, Francisco Javier LÓPEZ ROMÁN, Vincente ÁVILA GANDÍA, Fernando CÁNOVAS GARCÍA
  • bacterium for treatment of e.g. bacterial vaginosis
    Patent number: 11202813
    Abstract: A novel lactic acid Lactobacillus rhamnosus bacterium suitable for treatment of e.g. bacterial vaginosis.
    Type: Grant
    Filed: March 3, 2020
    Date of Patent: December 21, 2021
    Assignee: FERRING B.V.
    Inventors: Maria Empar Chenoll Cuadros, Beatriz Casinos Ramo, Angela Silva Angulo, Daniel Ramon Vidal, Salvador Genoves Martinez
  • Strain of subsp. lactis CECT 8145 and use thereof for the treatment and/or prevention of excess weight and obesity and associated diseases
    Patent number: 10946051
    Abstract: The invention is applicable within the food and pharmaceutical industry. More specifically, it relates to a novel strain of the species Bifidobacterium animalis subsp. lactis CECT 8145, the cell components, metabolites and secreted molecules thereof, which, incorporated into food and/or pharmaceutical formulations, can be used in the treatment and/or prevention of excess weight and obesity and related diseases such as metabolic syndrome, hypertension, glycemia, inflammation, type 2 diabetes, cardiovascular diseases, hypercholesterolemia, hormonal alterations, infertility, etc.
    Type: Grant
    Filed: July 17, 2014
    Date of Patent: March 16, 2021
    Assignee: BIOPOLIS, S.L.
    Inventors: Patricia Martorell Guerola, Mª Empar Chenoll Cuadros, Daniel Ramón Vidal, Pepa Ortiz Serrano, Silvia Llopis Pla, Núria Gonzalez Martínez, Salvador Genovés Martínez, Beatriz Casinos Ramo, Ángela Silva Angulo, Amaya Aleixandre
  • Use of probiotics in the treatment and/or prevention of psoriasis
    Patent number: 10912802
    Abstract: The present invention is intended for the use of a probiotic composition comprising Bifidobacterium animalis subs. lactis (B. lactis), Bifidobacterium longum and Lactobacillus rhamnosus, in particular the strains B. lactis CECT 8145, B. longum ES1 CECT 7347 and/or L. rhamnosus CECT 8361, in the treatment and/or prevention of psoriasis outbreaks or psoriasis.
    Type: Grant
    Filed: March 21, 2017
    Date of Patent: February 9, 2021
    Assignees: Bionou Research, S.L., KOROTT, S.L., BIOPOLIS, S.L.
    Inventors: Vicente Manuel Navarro López, Ana Adela Ramírez Boscá, José Manuel Pérez Orquín, Daniel Ramón Vidal, Salvador Genovés Martínez, María Empar Chenoll Cuadros, Francisco Manuel Codoñer Cortés
  • LACTOBACILLUS RHAMNOSUS BACTERIUM FOR TREATMENT OF E.G. BACTERIAL VAGINOSIS
    Publication number: 20200268815
    Abstract: A novel lactic acid Lactobacillus rhamnosus bacterium suitable for treatment of e.g. bacterial vaginosis.
    Type: Application
    Filed: March 3, 2020
    Publication date: August 27, 2020
    Applicant: Ferring B.V.
    Inventors: Maria Empar CHENOLL CUADROS, Beatriz CASINOS RAMO, Angela SILVA ANGULO, Daniel RAMON VIDAL, Salvador GENOVES MARTINEZ
  • Lactic acid bacteria for coeliac disease
    Patent number: 10603342
    Abstract: The present invention discloses strains of Lactobacillus and Streptococcus which have a capacity to degrade gliadin peptides involved in coeliac disease and which peptide degrading activity is stable under low pH and in the presence of mammalian digestive enzymes. These strains are suitable in a product for use in prevention and/or treatment of celiac disease.
    Type: Grant
    Filed: October 6, 2016
    Date of Patent: March 31, 2020
    Assignee: Compagnie Gervais Danone
    Inventors: Agusti Montserrat Carreras, Montserrat Andreu Corominas, Daniel Ramon Vidal, Salvador Genoves Martinez, Esther Bataller Leiva
  • bacterium for treatment of e.g. bacterial vaginosis
    Patent number: 10588926
    Abstract: A novel lactic acid Lactobacillus rhamnosus bacterium suitable for treatment of e.g. bacterial vaginosis.
    Type: Grant
    Filed: June 29, 2016
    Date of Patent: March 17, 2020
    Assignee: FERRING B.V.
    Inventors: Maria Empar Chenoll Cuadros, Beatriz Casinos Ramo, Angela Silva Angulo, Daniel Ramon Vidal, Salvador Genoves Martinez
  • USE OF PROBIOTICS IN THE TREATMENT AND/OR PREVENTION OF PSORIASIS
    Publication number: 20190328799
    Abstract: The present invention is intended for the use of a probiotic composition comprising Bifidobacterium animalis subs. lactis (B. lactis), Bifidobacterium longum and Lactobacillus rhamnosus, in particular the strains B. lactis CECT 8145, B. longum ES1 CECT 7347 and/or L. rhamnosus CECT 8361, in the treatment and/or prevention of psoriasis outbreaks or psoriasis.
    Type: Application
    Filed: March 21, 2017
    Publication date: October 31, 2019
    Inventors: Vicente Manuel NAVARRO LÓPEZ, Ana Adela RAMÍREZ BOSCÁ, José Manuel PÉREZ ORQUÍN, Daniel RAMÓN VIDAL, Salvador GENOVÉS MARTÍNEZ, MarÍa Empar CHENOLL CUADROS, Francisco CODOÑER CORTÉS
  • Use of probiotics to increase male fertility
    Patent number: 10434127
    Abstract: The present invention relates to the use of Lactobacillus rhamnosus in combination with Bifidobacterium longum to manufacture a formulation to increase male fertility in a subject. In particular, said strains are the strains Lactobacillus rhamnosus CECT 8361 and Bifidobacterium longum CECT 7347. Additionally, the formulation comprising the said strains Lactobacillus rhamnosus CECT 8361 and Bifidobacterium longum CECT 7347 is also described.
    Type: Grant
    Filed: December 23, 2015
    Date of Patent: October 8, 2019
    Assignees: UNIVERSIDAD DE LEÓN, Biopolis, S.L.
    Inventors: Vanesa Robles Rodríguez, David García Valcarce, Daniel Ramón Vidal, Salvador Genovés Martínez, Patricia Martorell Guerola, Ma Empar Chenoll Cuadros
  • USE OF PROBIOTICS IN THE TREATMENT AND/OR PREVENTION OF ATOPIC DERMATITIS
    Publication number: 20190282636
    Abstract: The present invention is intended for the use of a probiotic composition comprising Bifidobacterium animalis subs. lactis (B. lactis), Bifidobacterium longum and Lactobacillus casei, particularly the strains B. lactis CECT 8145, B. longum CECT 7347 and/or L. casei CECT 9104, in the treatment and/or prevention of atopic dermatitis.
    Type: Application
    Filed: July 18, 2017
    Publication date: September 19, 2019
    Inventors: Vicente Manuel NAVARRO LÓPEZ, Ana Adela RAMÍREZ BOSCÁ, José Manuel PÉREZ ORQUÍN, Daniel RAMÓN VIDAL, Salvador GENOVÉS MARTÍNEZ, Maria Empar CHENOLL CUADROS, Francisco Manuel CODOÑER CORTÉS
  • LACTOBACILLUS RHAMNOSUS BACTERIUM FOR TREATMENT OF E.G. BACTERIAL VAGINOSIS
    Publication number: 20180228850
    Abstract: A novel lactic acid Lactobacillus rhamnosus bacterium suitable for treatment of e.g. bacterial vaginosis.
    Type: Application
    Filed: June 29, 2016
    Publication date: August 16, 2018
    Applicant: FERRING B.V.
    Inventors: Maria Empar CHENOLL CUADROS, Beatriz CASINOS RAMO, Angela SILVA ANGULO, Daniel RAMON VIDAL, Salvador GENOVES MARTINEZ
  • USE OF PROBIOTICS TO INCREASE MALE FERTILITY
    Publication number: 20180071347
    Abstract: The present invention relates to the use of Lactobacillus rhamnosus in combination with Bifidobacterium longum to manufacture a formulation to increase male fertility in a subject. In particular, said strains are the strains Lactobacillus rhamnosus CECT 8361 and Bifidobacterium longum CECT 7347. Additionally, the formulation comprising the said strains Lactobacillus rhamnosus CECT 8361 and Bifidobacterium longum CECT 7347 is also described.
    Type: Application
    Filed: December 23, 2015
    Publication date: March 15, 2018
    Inventors: VANESA ROBLES RODRÍGUEZ, DAVID GARCÍA VALCARCE, DANIEL RAMÓN VIDAL, SALVADOR GENOVÉS MARTÍNEZ, PATRICIA MARTORELL GUEROLA, Mª EMPAR CHENOLL CUADROS
  • strain for reducing body fat accumulation
    Patent number: 9855304
    Abstract: The invention relates to the use of Lactobacillus rhamnosus strain CNCM 1-3690 for reducing body fat accumulation and treating disorders resulting therefrom, such as overweight, obesity, and obesity-related disorders.
    Type: Grant
    Filed: November 12, 2012
    Date of Patent: January 2, 2018
    Assignees: Compagnie Gervais Danone, Biopolis S.L.
    Inventors: Gianfranco Grompone, Daniel Ramon Vidal, Patricia Martorell Guerola, Salvador Genoves Martinez, Josefa Ortiz Serrano, Silvia Llopis Pla, Nuria Gonzalez Martinez
  • Functional peptides for obesity disorders
    Patent number: 9802990
    Abstract: The present invention concerns certain peptides obtainable by hydrolysis from soy glycinin by the action of supernatant cultures of strains belonging to the genera Lactobacillus or Streptococcus. These peptides, extracts containing them and food products containing them are useful for the treatment and/or prevention of obesity and oxidative stress.
    Type: Grant
    Filed: February 19, 2013
    Date of Patent: October 31, 2017
    Assignee: DANONE, S.A.
    Inventors: Agusti Montserrat Carreras, Cristina Alvarez Fernandez, Montserrat Andreu Corominas, Daniel Ramón Vidal, Esther Bataller Leiva, Patricia Martorell Guerola, Salvador Genovés Martínez
  • Lactic Acid Bacteria for Coeliac Disease
    Publication number: 20170145379
    Abstract: The present invention discloses strains of Lactobacillus and Streptococcus which have a capacity to degrade gliadin peptides involved in coeliac disease and which peptide degrading activity is stable under low pH and in the presence of mammalian digestive enzymes. These strains are suitable in a product for use in prevention and/or treatment of celiac disease.
    Type: Application
    Filed: October 6, 2016
    Publication date: May 25, 2017
    Inventors: Agusti Montserrat Carreras, Montserrat Andreu Corominas, Daniel Ramon Vidal, Salvador Genoves Martinez, Esther Bataller Leiva
  • NOVEL STRAIN OF BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS CECT 8145 AND USE THEREOF FOR THE TREATMENT AND/OR PREVENTION OF EXCESS WEIGHT AND OBESITY AND ASSOCIATED DISEASES
    Publication number: 20160143963
    Abstract: The invention is applicable within the food and pharmaceutical industry. More specifically, it relates to a novel strain of the species Bifidobacterium animalis subsp. lactis CECT 8145, the cell components, metabolites and secreted molecules thereof, which, incorporated into food and/or pharmaceutical formulations, can be used in the treatment and/or prevention of excess weight and obesity and related diseases such as metabolic syndrome, hypertension, glycemia, inflammation, type 2 diabetes, cardiovascular diseases, hypercholesterolemia, hormonal alterations, infertility, etc.
    Type: Application
    Filed: July 17, 2014
    Publication date: May 26, 2016
    Inventors: Patricia MARTORELL GUEROLA, Mª Empar CHENOLL CUADROS, Daniel RAMÓN VIDAL, Pepa ORTIZ SERRANO, Silvia LLOPIS PLA, Núria GONZALEZ MARTÍNEZ, Salvador GENOVÉS MARTÍNEZ, Beatriz CASINOS RAMO, Ángela SILVA ANGULO, Amaya ALEIXANDRE
  • FUNCTIONAL PEPTIDES FOR OBESITY DISORDERS
    Publication number: 20160002303
    Abstract: The present invention concerns certain peptides obtainable by hydrolysis from soy glycinin by the action of supernatant cultures of strains belonging to the genera Lactobacillus or Streptococcus.
    Type: Application
    Filed: February 19, 2013
    Publication date: January 7, 2016
    Applicant: DANONE, S.A.
    Inventors: Agusti MONTSERRAT CARRERAS, Cristina ALVAREZ FERNÁNDEZ, Montserrat ANDREU COROMINAS, Daniel RAMÓN VIDAL, Esther BATALLER LEIVA, Patricia MARTORELL GUEROLA, Salvador GENOVÉS MARTÍNEZ
  • Lactobacillus Rhamnosus Strain for Reducing Body Fat Accumulation
    Publication number: 20150283186
    Abstract: The invention relates to the use of Lactobacillus rhamnosus strain CNCM 1-3690 for reducing body fat accumulation and treating disorders resulting therefrom, such as overweight, obesity, and obesity-related disorders.
    Type: Application
    Filed: November 12, 2012
    Publication date: October 8, 2015
    Applicants: COMPAGNIE GERVAIS DANONE, BIOPOLIS, S.L.
    Inventors: Gianfranco Grompone, Daniel Ramon Vidal, Patricia Martorell Guerola, Salvador Genoves Martinez, Pepa Ortiz Soriano, Silvia Llopis Pla, Nuria Gonzalez Martinez
  • Obtaining cocoa extracts rich in bioactive peptides with ACE and PEP enzyme inhibitory activity
    Patent number: 8946383
    Abstract: The present invention relates to obtaining bioactive peptides from plant raw materials, specifically cocoa extracts, by means of enzyme treatment. Said biopeptides have angiotensin converting enzyme (ACE) and prolyl endopeptidase enzyme (PEP) inhibitory activity in vitro and/or antioxidant activity in vivo, being able to be used in the food, dietetic and pharmaceutical industry.
    Type: Grant
    Filed: August 1, 2008
    Date of Patent: February 3, 2015
    Assignee: Naturex
    Inventors: Begoña Muguerza Marquínez, Honorato Monzo Oltra, Natalia Alepuz Rico, Esther Bataller Leiva, Salvador Genoves Martínez, Maria Enrique López, Patricia Guerola Guerola, Daniel Ramon Vidal